In order to further elaborate the immunopathological roles of IL-31 and IL-33 in AD, future study for the IL-31 and IL-33 activating effects on skin-resident eosinophils and dermal fibroblasts obtained from AD patients is needed. Here, IL31 is linked to Alzheimer disease.